Ewings Sarcoma clinical trials

Explore recruiting ewings sarcoma clinical trials.

Recruiting ewings sarcoma studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Ewings Sarcoma trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

J1S-MC-JP04: A Randomized, Open-Label Phase 2 Study Evaluating Abemaciclib in Combination with Irinotecan and Temozolomide in Participants with Relapsed or Refractory Ewing’s Sarcoma

Italy, Spain, France, Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

Ewings Sarcoma trials by city

Ewings Sarcoma in Toronto Ewings Sarcoma in Vancouver Ewings Sarcoma in Montreal Ewings Sarcoma in Calgary Ewings Sarcoma in Edmonton Ewings Sarcoma in Ottawa Ewings Sarcoma in Winnipeg Ewings Sarcoma in Quebec City Ewings Sarcoma in Hamilton Ewings Sarcoma in Kitchener Ewings Sarcoma in London Ewings Sarcoma in Halifax Ewings Sarcoma in New York Ewings Sarcoma in Los Angeles Ewings Sarcoma in Chicago Ewings Sarcoma in Houston

Ewings Sarcoma clinical trials

Recruiting ewings sarcoma studies right now

Biologically-Adapted, Dose-Escalated Radiotherapy for the Treatment of Ewing Sarcoma, BEAR Trial

Personalized Vaccination in Fusion+ Sarcoma Patients (PerVision)

Alpha/Beta T and B Cell Depletion With Zoledronic Acid for Solid Tumors

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors

Indocyanine Green (ICG) Guided Tumor Resection

Efficacy and Safety of Regorafenib as Maintenance Therapy After First-line Treatment in Patients With Bone Sarcomas

Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma

Phase 1/2 Trial to Evaluate the Safety and Efficacy of PEEL-224 in Combination With Vincristine and Temozolomide in Adolescents and Young Adults With Relapsed or Refractory Sarcomas

Selective Antigen Specific T Cells and CAR T Cells in Subjects With Relapsed/Refractory Embryonal Tumors (SABRE)

Lurbinectedin in FET-Fused Tumors

Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas

Also recruiting in Europe

J1S-MC-JP04: A Randomized, Open-Label Phase 2 Study Evaluating Abemaciclib in Combination with Irinotecan and Temozolomide in Participants with Relapsed or Refractory Ewing’s Sarcoma

Ewings Sarcoma trials by city

Other conditions